Company Overview
Snapshot
Founded in January 2024 by Dan Davidi, OHR Synbiosis operates with 11–50 employees. The company is currently in a Pre-Funding stage, focusing on developing its sustainable chemical manufacturing platform.
Business overview
OHR Synbiosis is a synthetic biology company that develops a novel platform for sustainable chemical manufacturing. The company leverages engineered enzymes to transform CO₂-derived feedstocks into precise carbon chains, aiming to eliminate the need for traditional petroleum-based refining processes. This technology enables the production of bio-based materials, such as sulfur-free fuels, supporting decarbonization and circular economy solutions. OHR Synbiosis offers a scalable and cost-effective alternative to conventional petrochemical manufacturing, with applications across various industries, operating within the Industrial Technologies sector, specifically in Material Innovations & Applications and Sustainable Materials & Circularity.
Log in to access full profile ›Company Intelligence Q&A
- What is OHR Synbiosis's primary focus?
- OHR Synbiosis focuses on developing a novel platform for sustainable chemical manufacturing using synthetic biology.
- When was OHR Synbiosis founded?
- OHR Synbiosis was founded in January 2024.
- Who is the founder of OHR Synbiosis?
- Dan Davidi is the founder and CEO of OHR Synbiosis.
- What technology does OHR Synbiosis utilize?
- OHR Synbiosis leverages engineered enzymes to transform CO₂-derived feedstocks into precise carbon chains, offering an alternative to petroleum-based refining.
- What kind of materials does OHR Synbiosis aim to produce?
- OHR Synbiosis aims to produce bio-based materials, including sulfur-free fuels, to support decarbonization and circular economy solutions.